These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28498925)

  • 21. Use of oral typhoid vaccine strain Ty21a in a New York state travel immunization facility.
    Rahman S; Barr W; Hilton E
    Am J Trop Med Hyg; 1993 Jun; 48(6):823-6. PubMed ID: 8333576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Typhus epidemiology in Switzerland 1980-1983. Slight or lack of effectiveness of the live vaccine Vivotif in tropical travel].
    Wüthrich RP; Somaini B; Steffen R; Hirschel B
    Schweiz Med Wochenschr; 1985 Nov; 115(48):1714-20. PubMed ID: 4081702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012.
    Jones C; Lee CK; Ahn C; Shin J; Knezevic I
    Vaccine; 2013 Sep; 31(41):4466-9. PubMed ID: 23933367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.
    Begier EM; Burwen DR; Haber P; Ball R;
    Clin Infect Dis; 2004 Mar; 38(6):771-9. PubMed ID: 14999618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial.
    Yang J; Acosta CJ; Si GA; Zeng J; Li CY; Liang DB; Ochiai RL; Page AL; Danovaro-Holliday MC; Zhang J; Zhou BD; Liao HZ; Wang ML; Tan DM; Tang ZZ; Gong J; Park JK; Ali M; Ivanoff B; Liang GC; Yang HH; Pang T; Xu ZY; Donner A; Galindo CM; Dong BQ; Clemens JD
    BMC Public Health; 2005 May; 5():49. PubMed ID: 15904514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new look at typhoid vaccination. Information for the practicing physician.
    Woodruff BA; Pavia AT; Blake PA
    JAMA; 1991 Feb; 265(6):756-9. PubMed ID: 1990193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of Typhim Vi vaccine in a postmarketing observational study.
    Marcus LC; Froeschle JE; Hill DR; Wolfe MS; Maus D; Connor B; Acosta AM; Rensimer ER; Roberts A; Dardick K
    J Travel Med; 2007; 14(6):386-91. PubMed ID: 17995534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactive arthritis associated with typhoid vaccination in travelers: report of two cases with negative HLA-B27.
    Adachi JA; D'Alessio FR; Ericsson CD
    J Travel Med; 2000 Jan; 7(1):35-6. PubMed ID: 10689239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ; Koo HW; Wang XY; Zhang J; Park JK; Zhu F; Deen J; Acosta CJ; Chen Y; Wang H; Galindo CM; Ochiai L; Park T; von Seidlein L; Xu ZY; Clemens JD
    Pediatr Infect Dis J; 2007 Nov; 26(11):1001-5. PubMed ID: 17984806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Typhoid fever: from parenteral to oral vaccines].
    Lopalco PL; Prato R; Germinario C
    Ann Ig; 2002; 14(3 Suppl 3):27-32. PubMed ID: 12389408
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-typhoid vaccines].
    Morand P; Stahl JP
    Rev Prat; 1992 Nov; 42(18):2292-4. PubMed ID: 1296295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: oral vaccines in HIV.
    Banda R; Yambayamba V; Lalusha BD; Sinkala E; Kapulu MC; Kelly P
    Vaccine; 2012 Aug; 30(38):5656-60. PubMed ID: 22789509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform.
    Agtini MD; Ochiai RL; Soeharno R; Lee HJ; Sundoro J; Hadinegoro SR; Han OP; Tana L; Halim FX; Ghani L; Delima ; Lestari W; Sintawati FX; Kusumawardani N; Malik R; Santoso TS; Nadjib M; Soeroso S; Wangsasaputra F; Ali M; Ivanoff B; Galindo CM; Pang T; Clemens JD; Suwandono A; Acosta CJ
    Public Health; 2006 Nov; 120(11):1081-7. PubMed ID: 17005220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Abdominal typhoid following vaccination with the attenuated vaccine Vivotif].
    Straumann A; Gyr N; Thommen A; Müller R
    Schweiz Med Wochenschr; 1983 Aug; 113(34):1205. PubMed ID: 6623044
    [No Abstract]   [Full Text] [Related]  

  • 39. [Abdominal typhus following vaccination with the live vaccine Vivotif].
    Hirschel BJ; Hirschel-Scholz S; Lüthy R; Bonetti A
    Schweiz Med Wochenschr; 1983 Apr; 113(16):605-7. PubMed ID: 6867651
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area.
    Ferreccio C; Levine MM; Rodriguez H; Contreras R
    J Infect Dis; 1989 Apr; 159(4):766-9. PubMed ID: 2647863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.